Dr. Vince Clinical Research (DVCR) announced the expansion of its research campus by constructing a new 5,000-square-foot administration building in Overland Park, Kansas. This project continues its breakthrough expansion for the company as it enhances its clinical research capabilities and services. The organization currently has well over 175 employees across the United States, Canada, Europe and the United Kingdom.
The new administration building will support finance, human resources and volunteer recruitment departments, enabling operational efficiencies and enhancing service offerings to better serve the needs of its clients. Strategically located on the current 75,000-square-foot research campus, the new building will mirror the existing headquarters, providing architectural and design continuity.
“We are proud to commence construction on yet another building on our research campus,” stated Dr. Brad Vince, CEO and Chief Medical Officer at Dr. Vince Clinical Research.
“Our original goal was to create a world-class contract research organization. The new administration building will help us achieve this goal by further facilitating our day-to-day operations and fostering collaboration and innovation amongst our team,” added Dr. Vince.
The expansion project received unanimous approval from the Overland Park Planning Commission in March 2024, highlighting the support and enthusiasm for Dr. Vince Clinical Research's growth within the community and the biopharmaceutical industry. Construction has just commenced with completion expected within one year.